Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Therapeutic Advances in Endocrinology and Metabolism, 2025Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses
Zhang Y., Wang B., Chen B. et al.
Olink Explore 3072/384
Journal of Infection, 2025Multi-omics analysis of human plasma reveals reprogramming of tryptophan metabolism associated with inflammation in Mycoplasma pneumoniae pneumonia in children
Tang Y., Fu X., Li X. et al.
The American Journal of Pathology, 2025Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial Hypertension
Kuwabara Y., Yokokawa T., Lemay S. et al.
Health Science Reports, 2025Unveiling the Intricate Causal Nexus Between 91 Circulating Inflammatory Proteins and Perianal Abscess Through a Comprehensive Bidirectional Two‐Sample Mendelian Randomization Analysis
Wang Z., Chen T., Shi H. et al.
Olink Target 96
Cancer Communications, 2025First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial
Cheng Y., Zhang S., Han L. et al.
Scientific Reports, 2025High content imaging shows distinct macrophage and dendritic cell phenotypes for psoriasis and atopic dermatitis
Behr N., Pierre S., Ickelsheimer T. et al.
Nature Aging, 2025The geroprotectors trametinib and rapamycin combine additively to extend mouse healthspan and lifespan
Gkioni L., Nespital T., Baghdadi M. et al.
Olink Target 96 Mouse
Diabetology & Metabolic Syndrome, 2025Decoding the impact of glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist on cardiometabolic health: inflammatory mediators at the focus
Cheng F., Niu X., Wang Y. et al.
iScience, 2025Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study
Brake J., Ajie M., Sumpter N. et al.
eBioMedicine, 2025Radiomic and proteomic signatures of body mass index on brain ageing and Alzheimer's-like patterns of brain atrophy
Anagnostakis F., Kokkorakis M., Walker K. et al.
Diabetology & Metabolic Syndrome, 2025Spontaneous brain activity in patients with type 2 diabetes: linking serum neuroproteins to cognitive ability
Zhang Z., Wang W., Yang X. et al.
International Journal of Biological Macromolecules, 2025Causal relationship between 91 circulating inflammatory proteins and gynecological diseases: A two-sample bidirectional Mendelian randomization study
Wang J., Zhang P., Yuan J. et al.
Advanced Science, 2025Colorectal Cancer Cells–Derived Exosomal PIK3CA Mutation DNA Promotes Tumor Metastasis by Activating Fibroblast and Affecting Tumor Metastatic Microenvironment
Wang R., Li W., Lv Y. et al.
Liver Cancer, 2025Camrelizumab combined with Lenvatinib and RALOX-HAIC for unresectable hepatocellular carcinoma (Cal Era): a prospective, single-arm, phase II trial
Zang M., Li Q., Hu X. et al.
Nature Communications, 2025Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk
Zalesky A., Tian Y., Ferrucci L. et al.
Thrombosis Journal, 2025Therapeutic targets for venous thromboemblism: proteome-wide mendelian randomization and colocalization analyses
Li X., Yang C., Zhou M. et al.
Infection, 2025Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection
Chang C., Ma Z., Ren W. et al.
Journal of Inflammation Research, 2025Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome
Sun S., Li M., Song J. et al.
Nature Communications, 2025The health impacts and genetic architecture of food liking in cardio-metabolic diseases
Jiang W., Wang H., Geng Y. et al.
European Neuropsychopharmacology, 2025Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis
Oliva V., Possidente C., Fanelli G. et al.
3026 publications
Items per page
181-200 of 3026 publications